Back to Search Start Over

Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles.

Authors :
Mandoko, Papy Nkoli
Rouvier, Florent
Kakina, Lebon Matendo
Mbongi, Destin Moke
Latour, Christine
Likwela, Joris Losimba
Mumba, Dieudonné Ngoyi
Shamamba, Stomy Karhemere Bi
Muyembe, Jean-Jacques Tamfum
Tshilolo, Léon Muepu
Nkoli Mandoko, Papy
Matendo Kakina, Lebon
Moke Mbongi, Destin
Losimba Likwela, Joris
Ngoyi Mumba, Dieudonné
Bi Shamamba, Stomy Karhemere
Tamfum Muyembe, Jean-Jacques
Muepu Tshilolo, Léon
Parzy, Daniel
Sinou, Véronique
Source :
Journal of Antimicrobial Chemotherapy (JAC); Oct2018, Vol. 73 Issue 10, p2704-2715, 12p
Publication Year :
2018

Abstract

<bold>Background: </bold>In 2005, the Democratic Republic of the Congo (DRC) switched to artesunate/amodiaquine as the first-line antimalarial in response to increasing sulfadoxine/pyrimethamine resistance and adopted intermittent preventive treatment using sulfadoxine/pyrimethamine in pregnancy.<bold>Objectives: </bold>To determine the prevalence of molecular markers of sulfadoxine/pyrimethamine resistance in southwestern DRC 10 years after the new policy was instituted.<bold>Methods: </bold>From March 2014 to December 2015, blood samples were collected from symptomatic patients presenting to outpatient centres in urban and rural areas. A total of 2030 confirmed Plasmodium falciparum isolates were genotyped at codons associated with sulfadoxine/pyrimethamine resistance.<bold>Results: </bold>The prevalence of pfdhfr-N51I, C59R and S108N and pfdhps-A437G mutations was consistently high; the prevalence of the pfdhps-K540E mutation was low but increased since its first report in 2008 in the same region, reaching 17.6% by 2015. The pfdhps-A581G mutation increased from ∼4.5% in 2014 to ∼14.0% in 2015 at urban sites while in rural areas it remained low (∼4.0%). The mutations pfdhfr-I164L and pfdhps-A613S were detected for the first time in DRC. Also, 11 (0.8%) isolates revealed the presence of the newly described pfdhps-I431V mutation. Combining pfdhfr and pfdhps alleles, quintuple and sextuple mutations were observed, with the emergence of septuple (IRNI/IAGEGA)- and octuple (IRNI/VAGKGS)-mutant genotypes.<bold>Conclusions: </bold>Intermittent preventive treatment using sulfadoxine/pyrimethamine during pregnancy remains warranted in southwestern DRC. However, the expansion of pfdhps-K540E mutation and emergence of mutants that cause higher levels of sulfadoxine/pyrimethamine resistance is concerning and may present a challenge for future preventive interventions in the country. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03057453
Volume :
73
Issue :
10
Database :
Complementary Index
Journal :
Journal of Antimicrobial Chemotherapy (JAC)
Publication Type :
Academic Journal
Accession number :
131920682
Full Text :
https://doi.org/10.1093/jac/dky258